AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04909333 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Exenatide
Description: Day1: After a standardized night meal (Maizena 40g plus dessert) at 22 p.m. on the day before, patients receive Exenatide study medication according to the randomization list (injection done slowly over 2 min.). Regular clinical examination of vegetative and neurological state will be done as well as continuous blood sugar measurements and blood withdrawals will be performed.~Day2:~The procedure is equal to study day 1. Instead of Exenatide, a 10ml 0.9% saline solution will be administered intravenously.
Study NCT04909333 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 0.9% saline solution
Description: Day1: After a standardized night meal (Maizena 40g plus dessert) at 22 p.m. on the day before, patients receive 0.9% saline solution according to the randomization list (injection done slowly over 2 min.). Regular clinical examination of vegetative and neurological state will be done as well as continuous blood sugar measurements and blood withdrawals will be performed.~Day2:~The procedure is equal to study day 1. Instead of 0.9% saline solution, Exenatide will be administered intravenously.
Study NCT06346496 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Douyin Xinqing AI dialog bot
Description: Douyin Xinqing is an AI dialog bot. Users can start chatting with the Douyin companion bot by clicking on the Direct Message on the homepage of their accounts on Douyin app.~After a user sends any message to the Douyin companion bot, it first asks the user about his or her mood and guides him or her to start chatting around his or her emotions. According to the situation described by the user, the companion bot expresses empathy, asks questions to guide the user to talk, and provides suggestions at the appropriate time. Users can also record their emotions every day and look back regularly to observe changes in their inner feelings. In addition, the Douyin companion bot can also identify crisis situations such as suicide and severe mental illness and, if necessary, guide users to call the hotline to obtain professional psychological assistance.
Study NCT06346496 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Douyin Xinqing AI dialog bot for delayed intervention
Description: Only the users in the waiting group had the task of waiting for the first four weeks, and they completed the three questionnaires at exactly the same point in time as those in the intervention group. Only after the first four weeks of intervention did the waiting group begin to receive the 28-day conversational intervention, and no additional questionnaires were interspersed in between.
Study NCT06234657 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Telerehabilitation for stroke patient
Description: The subjects of the study were intervened by telerehabilitation through video instructions and online group training via Online meeting software. The content of the intervention program included upper limb exercises, transfer, and ambulation functions. This training program was designed based on the clinical practice guidelines for post-stroke physiotherapy management from the United States Department of Veterans Affairs and the guidelines for the diagnosis, and treatment of rehabilitation stroke patients of the Vietnam Ministry of Health. The training results of the subjects will be evaluated by the Barthel Index
Study NCT05576740 — intervention group
Intervention type: PROCEDURE
Intervention: Determination of hormone level concentrations
Description: Determination of concentration of 17β-oestradiol (pg/mL), progesterone (ng/mL), LH (mUI/mL), FSH (mUI/mL), prolactin (ng/mL), total testosterone (ng/mL), free testosterone (pmol/L) sex hormone binding globulin (SHBG) (nmol/L), cortisol (μg/dL), T3 (ng/dL), T4 (mcg/dL), TSH (mcU/mL), basal insulin (mcUI/mL) during the early follicular phase, late follicular phase, and mid-luteal phase.
Study NCT05576740 — intervention group
Intervention type: PROCEDURE
Intervention: Jump height determination
Description: by Chronojump contact mat, determine five types of jump in centimeters: Squat jump without additional weight, Squat jump with 50% of body weight, Countermovement jump, Abalakov jump, and Drop jump, during the early follicular phase, late follicular phase, and mid-luteal phase.
Study NCT05456568 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: LymphAssistTM Professional
Description: An intermittent pneumatic compression (IPC) device that mimics manual lymphatic drainage. Participants use the device daily for 12 weeks alongside their usual and standard lymphoedema care
Study NCT06425939 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Force plate assessment
Description: On Day 1, Day 45 and Day 90: 3x drop jumps, 2 min rest, 3x counter movement jumps, 2 min rest, 3x dynamic push-ups
Study NCT06425939 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Whoop wrist band
Description: Whoop wrist worn activity tracker (not a medical device) collects continuous data via smartphone app. This is a marketed device. This is not a device study.
Study NCT05346965 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Musical training
Description: The musical training intervention comprised songs, rhythm and visual creativity to encourage the children to experience music-making as fun.
Study NCT05346965 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Musical training
Description: The musical training intervention comprised songs, rhythm and visual creativity to encourage the children to experience music-making as fun.
Study NCT05146713 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Propolis nanoparticles extract solution
Description: 20 mg/ml propolis nanoparticles in the form of solution prepared from honeybee from various plants.
Study NCT05146713 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: sodium hypochlorite
Description: 2.5% sodium hypochlorite (household bleaching agent)
Study NCT04935359 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NIS793
Description: Concentrate for solution infusion (Liquid in Vial)
Study NCT04935359 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nab-paclitaxel
Description: Per locally approved formulation
Study NCT04935359 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Nab-paclitaxel
Description: Per locally approved formulation
Study NCT04935359 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gemcitabine
Description: Per locally approved formulation
Study NCT04935359 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Gemcitabine
Description: Per locally approved formulation
Study NCT04935359 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Dextrose 5% in water (D5W) solution for infusion
Study NCT04935359 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Dextrose 5% in water (D5W) solution for infusion
Study NCT06058936 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: exercises using virtual reality technology
Description: this is a one-dimensional therapy game using (Handle/ or Multiball) five games are available for the Pablo©Handle which are (Recycle, Firefighters, Shooting Cans, Balloon, and Applehunter) The session will be 3 min for each game about 15 min for each session 3 times per week for 8 week
Study NCT06058936 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: exercises using virtual reality technology
Description: this is a one-dimensional therapy game using (Handle/ or Multiball) five games are available for the Pablo©Handle which are (Recycle, Firefighters, Shooting Cans, Balloon, and Applehunter) The session will be 3 min for each game about 15 min for each session 3 times per week for 8 week
Study NCT05740605 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Hand-Arm Bimanual Intensive Therapy Including Lower Extremities (HABIT-ILE)
Description: HABIT-ILE (Hand-Arm Bimanual Intensive Therapy including Lower Extremities) is an intensive therapy that continuously incorporates postural control and LE function. This motor learning-based approach include specificity of the practice, motivation, shaping of the task, intensive blocks of training and Hands-Off. Moreover, the therapy is goal-oriented to increase functional independence during daily living. This therapy has shown impressive improvements in children with PC.
Study NCT05740605 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Hand-Arm Bimanual Intensive Therapy Including Lower Extremities at home
Description: The HABIT-ILE therapy at home will follow the same principles as the classic HABIT-ILE. The therapy will take place in the patient's home and a close person (caregiver) will accompany the patient during the therapy. A device will be used to facilitate the implementation of home therapy. Supervision of the therapeutic process will be done remotely by a team of trained supervisors. One hour of remote supervision per day will be scheduled within 6.5 hours of therapy.
Study NCT05740605 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Follow-up Hand-Arm Bimanual Intensive Therapy Including Lower Extremities
Description: HABIT-ILE follow-up at home follow the same principles as classic HABIT-ILE but is delivered at the patient home with 4 hours per week in autonomy and 1 hour per week under supervision.
Study NCT05740605 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Follow-up Hand-Arm Bimanual Intensive Therapy Including Lower Extremities
Description: HABIT-ILE follow-up at home follow the same principles as classic HABIT-ILE but is delivered at the patient home with 4 hours per week in autonomy and 1 hour per week under supervision.
Study NCT05740605 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Usual Care
Description: Usual care is all the weekly physiotherapy and occupational therapy sessions that the patient usually receives.
Study NCT05740605 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Usual Care
Description: Usual care is all the weekly physiotherapy and occupational therapy sessions that the patient usually receives.
Study NCT06077136 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: whole body vibration
Description: 3 sessions per week consisted of different types of exercises, all of which were performed while the child will be is under WBV using (Galileo® MED 25 TT, Germany; 2021 model) with the following parameters:~* WBV session duration: 10 minutes (rest periods can be incorporated (1-2 minutes maximum 3 times during the session)~* frequency: 12 Hz~* Amplitude: 2 (fixed)~* duration of each exercise: 2-3 minutes~* starting positions differ according to each exercise; upper limb weight-bearing and weight shift (from prone, prone on elbows, sitting, standing).~* upper limb active exercises using toys/ balls / wand. Involving throwing, catching, transfer between both hands (according to the abilities of each child).~* coordination exercises by asking the child to approximate the index finger of both hands together, perform finger-to-nose (eyes open and closed), and finger-to-therapist finger exercises.
Study NCT06077136 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: standard physical therapy
Description: all children will receive regular exercises according to their developmental abilities such as stretching, strengthening, facilitation, or inhibition as well as functional exercises. exercise sessions will be 3 times per week fo
Study NCT06077136 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: standard physical therapy
Description: all children will receive regular exercises according to their developmental abilities such as stretching, strengthening, facilitation, or inhibition as well as functional exercises. exercise sessions will be 3 times per week fo
Study NCT05437900 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Pressure Microcatheter guided strategy - PIOS MC
Description: Use of Pressure Microcatheter during PCI. After the PCI, the patient will receive treatment according to the incremental optimization strategy (PIOS) .
Study NCT05437900 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Pressure Wire guided strategy - PIOS - PW
Description: Use of Pressure Wire during PCI. After the PCI, the patient will receive treatment according to the incremental optimization strategy (PIOS) .
Study NCT05437900 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Pressure Microcatheter guided strategy - Standard of care
Description: Use of Pressure Microcatheter during PCI. After the PCI, the patient will receive standard of care treatment.
Study NCT05437900 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Pressure Wire guided strategy - Standard of care
Description: Use of Pressure Wire during PCI. After the PCI, the patient will receive standard of care treatment.
Study NCT04385264 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine
Description: Day 0: 800mg PO OD (4 capsules) Days 1-5: 400mg PO OD (2 capsules daily)
Study NCT04385264 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Mannitol
Description: Day 0: 4 capsules PO OD Days 1-5: 2 capsules daily PO OD
Study NCT04773782 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: avapritinib
Description: oral administration
Study NCT06110897 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: High Dose Resistance Exercise Training
Description: Progressive resistance exercise training
Study NCT06110897 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Low Dose Resistance Exercise Training Group
Description: Progressive resistance exercise training
Study NCT05576740 — intervention group
Intervention type: PROCEDURE
Intervention: Grip strength determination
Description: measuring of changes in muscle strength by handgrip dynamometer in the hand to be tested (handgrip test) during the early follicular phase, late follicular phase, and mid-luteal phase. Three attempts on each hand.
Study NCT05576740 — intervention group
Intervention type: PROCEDURE
Intervention: Flexibility determination
Description: measurement of changes in the range of motion of the hamstring musculature, by sit and reach test (cm), during the early follicular phase, late follicular phase, and mid-luteal phase. Three tries.
Study NCT05576740 — intervention group
Intervention type: PROCEDURE
Intervention: Indirect maximum oxygen consumption determination
Description: by the Course Navette test, the indirect oxygen consumption is calculated using the formula: VO2max = (6xFA) - 27,4 (FA = Speed of the last stage of the test completed. It takes place during the early follicular phase, late follicular phase, and mid-luteal phase.
Study NCT05576740 — intervention group
Intervention type: DEVICE
Intervention: Sensory and pain threshold determination
Description: by electrical muscle stimulator (Digitimer DS7A), during the early follicular phase, late follicular phase, and mid-luteal phase.
Study NCT05576740 — intervention group
Intervention type: OTHER
Intervention: Physical and mental symptoms associated with the menstrual cycle
Description: By The Daily Record of Severity of Problems (DRSP) questionnaire, during a full menstrual cycle.
Study NCT05576740 — intervention group
Intervention type: DEVICE
Intervention: Daily activity
Description: by accelerometer (GENEActiv) during a full menstrual cylcle: Wrist-worn device measuring accelerations as a measure of daily activity, in cpm, counts per minute.
Study NCT04843449 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ASC40
Description: Oral tablets
Study NCT05576740 — intervention group
Intervention type: PROCEDURE
Intervention: Biochemical parameters determination
Description: Determination of concentration of iron (μg/dL), ferritin (ng/mL), and transferrin (mg/dL), during the early follicular phase, late follicular phase, and mid-luteal phase.
Study NCT05576740 — intervention group
Intervention type: PROCEDURE
Intervention: Blood count determination
Description: Determination of concentration of hemoglobin (g/dL), red blood cells (10\^6/μL), hematocrit (%), white blood cells (10\^3/μl), platelets (10\^3/μl), during the early follicular phase, late follicular phase, and mid-luteal phase.
Study NCT05576740 — intervention group
Intervention type: PROCEDURE
Intervention: Body composition parameters determination
Description: Determination of weight (kg), total body water (L), proteins (kg), minerals (kg), body fat mass (kg), body mass index (BMI) (kg/m2), basal metabolic rate (kcal) by Bioelectrical Impedance Analysis, during the early follicular phase, late follicular phase, and mid-luteal phase.
Study NCT05576740 — intervention group
Intervention type: PROCEDURE
Intervention: Vital signs
Description: Determination of blood pressure (mmHg) and heart rate (bpm) at baseline, one minute and three minutes after the Course Navette test
Study NCT05576740 — intervention group
Intervention type: OTHER
Intervention: Checking for correct use of contraceptive methods
Description: Pre-test questions about possible forgetfulness or mishandling of the method
Study NCT05576740 — intervention group
Intervention type: PROCEDURE
Intervention: Urinary LH determination
Description: Urine LH test strips are performed from day 8 of the cycle until positive.
Study NCT05931939 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Ileal Interposition
Description: Bariatric surgery by laparoscopic Ileal Interposition
Study NCT05931939 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Traditional surgical technique
Description: Bariatric surgery by laparoscopic traditional technique
Study NCT05156489 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Fractionated Laser (Pixel CO2-Alma)
Description: The Laser will be administered at baseline (visit 2, day 0), at visit 3 (day 28±4) and at visit 4 (day 56±4) into vestibule, following the IFU of the device.
Study NCT05505903 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Temerature measurement
Description: Temerature measurement on admission to WBN or NICU
Study NCT04843449 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Itraconazole
Description: Oral capsules
Study NCT04843449 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: rifampicin
Description: Oral capsules
Study NCT05948774 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MT200605 for Injection
Description: Two stages (SAD, MAD) were designed in this study. For SAD, the MT200605 will single Intravenous (IV) infusion for 1h with the dose level as 0.15 mg/kg、0.3 mg/kg、0.6 mg/kg、0.9 mg/kg、1.2 mg/kg. For MAD, the participants will IV infusion of the MT200605 for 7 days with 2 times per day under the dose level of 0.3 mg/kg、0.6 mg/kg、1.2 mg/kg. The dosing frequency will be Q12h. The drug/placebo in day 7 will be only administrated for 1 time on morning. The infusion duration will be 1h.
Study NCT05948774 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: MT200605 Placebo
Description: Two stages (SAD, MAD) were designed in this study. For SAD, the MT200605 Placebo will single Intravenous (IV) infusion for 1h with the dose level as 0.15 mg/kg、0.3 mg/kg、0.6 mg/kg、0.9 mg/kg、1.2 mg/kg. For MAD, the participants will IV infusion of the MT200605 Placebo for 7 days with 2 times per day under the dose level of 0.3 mg/kg、0.6 mg/kg、1.2 mg/kg. The dosing frequency will be Q12h. The drug/placebo in day 7 will be only administrated for 1 time on morning. The infusion duration will be 1h.
Study NCT05121142 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ruxolitinib
Description: Ruxolitinib will be given by mouth or enteral tube (if applicable).
Study NCT05099419 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Repetitive Transcranial Magnetic Stimulation
Description: rTMS uses pulses of magnetic energy to non-invasively stimulate the brain. The rTMS device to be used in this study is the Magstim Rapid2 Plus1. The rTMS device is connected to an active figure-of-eight coil which rests against the scalp and delivers the magnetic energy to the brain. The rTMS protocol is specified by the parameters of pulse frequency, duration of continuous pulse delivery, intensity, and stimulation location.~Each participant will receive two different standard rTMS protocols that have been used in past research studies for modulation of pelvic floor tone delivered over the motor cortex in an area that is known to control pelvic floor muscles.
Study NCT06511908 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: (2R,6R)-hydroxynorketamine (0.25 to 2.0 mg/kg)
Description: Arm 1 and 2 Experimental Intervention
Study NCT06511908 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Arm 1 and 2 Control Intervention
Study NCT05131074 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Collabree Mobile Phone Application Medication Adherence Booster
Description: Patients take part in a 90-day program to promote medication adherence and a 90-day follow-up through the Collabree application. Patients will receive more information as to the exact functions and use of the mobile phone application when the application is installed on their mobile phone.
Study NCT05131074 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Collabree Mobile Phone Application Medication Adherence Booster (simplified version)
Description: Patients take part in a 90-day program to promote medication adherence and a 90-day follow-up through the Collabree application. Patients will receive more information as to the exact functions and use of the mobile phone application when the application is installed on their mobile phone.
Study NCT05966168 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Medtronic Micra AV Device
Description: Participants will already be planned to have a Micra AV 2.0 device implanted. Participants will then undergo treadmill exercise testing and wear a Holter monitor to determine the effectiveness of the Micra AV 2.0 device during exercise or elevated heart rates.